Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer

Kucukdurmaz F., Efe E., Celik A., Dagli H., Kilinc M., Resim S.

BMC UROLOGY, cilt.17, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1186/s12894-017-0303-6
  • Dergi Adı: BMC UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Prostate cancer, Benign prostatic hyperplasia, Prolidase, Oxidative stress, ANTIOXIDANT STATUS, DNA-DAMAGE, HYPERPLASIA, PLASMA, DISEASE, MATRIX
  • Gazi Üniversitesi Adresli: Hayır

Özet

Background: Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are diseases of elderly men and are related to increased oxidative stress (OS). Although prolidase has a role in collagen metabolism, it is also used to evaluate OS in many diseases. However, there is a lack of data about serum prolidase activity (SPA) in prostate cancer. The aim of this study was to evaluate and compare SPA levels in males with BPH and PCa.